Bristol-Myers Squibb Company
BMYBristol-Myers Squibb Company (BMY) is a Healthcare company that currently yields 4.24% — trading near fair value based on 10 years of dividend yield history. The Weiss valuation model places the undervaluation threshold at $48.42 and the overvaluation threshold at $74.62. Bristol-Myers Squibb Company holds a quality score of 35/100 (Risky), reflecting 4 consecutive years of dividend growth with a 55% payout ratio. The 5-year dividend CAGR stands at 1.6%.
BMY Dividend Yield History — Weiss Valuation
Distance to undervalued
Waiting for a better entry
Needs about 18.6% downside to reach the Weiss buy zone
Undervaluation starts near $48.42, where the annual dividend would imply roughly 5.20% yield. That is 0.97% above today's yield.
Buy-zone price
$48.42
Target yield
5.20%
Research checklist
What to clear before buying the yield
Updated Oct 7, 2026
Dividend durability
4YVerify the dividend record before treating yield as durable.
Earnings payout
55%Earnings coverage leaves room for noise.
Cash payout
63%Free cash flow coverage supports the payment.
Dividend growth
1.6%Lower growth changes the return trade-off.
What changed
What changed since the last update
2026-10-06 → 2026-10-07
No major change in signal, yield, price, quality, or payout since the last update.
Why Now?
Bristol-Myers Squibb Company is trading at a fair valuation relative to its dividend history.
Current yield 4.2% vs historical max 6.2% (69% of maximum).
4 years of uninterrupted dividends.
Conservative payout ratio of 55%.
What matters now
Read the signal before the headline yield
Valuation is neutral here: quality has to do more of the work than entry price.
The 35/100 quality score says the headline yield needs extra skepticism.
Start by checking whether payout coverage and business durability still support the dividend.
BMY Dividend Income Projection — DRIP Compounder
Dividend Compounder (DRIP)
Year 1 Income
$430
Year 10 Income
$744
Yield on Cost
7.81%
Total Income
$5,720
Assumes dividends reinvested at current price. Simplified model — for illustrative purposes only.
Track actual vs. projected
See what BMY dividends you actually received with Sharesight
Dividend income log · Yield on cost · DRIP cost basis · Tax reports
More research
Full price history & technical analysis
TradingView ↗Fundamentals, valuation & analyst ratings
FinViz ↗Moat rating & analyst fair value
Morningstar ↗Track dividends received & tax reports
Sharesight ↗BMY Dividend Quality Score
Quality Score
Risky
Key Metrics
Invest in BMY
Check Bristol-Myers Squibb Company availability and current costs on eToro
Check eToro terms and availability →DividendVisual may earn a commission if you open an account via this link, at no cost to you. Capital at risk. Not financial advice.
In-depth analysis
→ BMY Dividend Analysis Article